Lithium aspartate does not provide significant relief for post-COVID-19 symptoms of fatigue or cognitive dysfunction.

Using single maintenance and reliever therapy (SMART) is cost‐effective vs ICS/LABA maintenance plus SABA reliever in uncontrolled asthma.

Postpartum diabetes risk was elevated among women with a history of gestational diabetes and a high-stable or inverse U-shaped BMI trajectory.

Topline results were announced from a phase 3 trial evaluating SC pembrolizumab with berahyaluronidase alfa in metastatic NSCLC.

Remdesivir plus dexamethasone vs dexamethasone alone reduces the risk of mortality among patients hospitalized with COVID-19.

Povidone-iodine vs chlorohexidine gluconate demonstrated a reduction in deep SSI, but an increased risk for overall and superficial SSI.

In IPF, antifibrotic therapy discontinuation was linked to patient variables that included depression, lower DLCO, and higher all-cause mortality.

Patients with HIV have higher risk for obstructive lung disease, gas exchange impairment, a rapid reduction in lung function, and emphysema.

Machine learning analysis of photo and video data demonstrates a promising way to noninvasively detect early hypertension and diabetes.

Influenza-related hospitalization rates in the US varied significantly from 2010/2011 through the 2022/2023, an MMWR report found.

Global coverage with measles vaccination declined during the COVID-19 pandemic, and estimated measles cases increased 20 percent worldwide from 2022 to 2023.

Casirivimab and imdevimab in combination is safe among pediatric outpatients with at least 1 risk factor for severe COVID-19.